AI-generated summary
The authors of this systematic review and meta-analysis pooled 13 randomized controlled studies on intense pulsed light therapy for dry eye symptoms caused by meibomian gland dysfunction. They report that IPL probably reduces symptoms compared with placebo, but the benefit as an add-on to standard care is unclear and the evidence on adverse events is very uncertain.
- Studies included
- 13
- Who or what was studied
- Patients with meibomian gland dysfunction and dry eye symptoms
- Limits stated in the abstract
- The risk of bias was moderate in most results, mainly due to selective reporting, and the certainty of evidence on adverse events is very low.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Dry eye disease is a common ocular condition, affecting quality of life and function for many people worldwide. This systematic review evaluates the effectiveness and safety of intense pulsed light (IPL) therapy for dry eye symptoms due to meibomian gland dysfunction (MGD), as they are not yet established.
Methods
Comprehensive searches were conducted in January 2024 (Cochrane Library, Embase, MEDLINE). We included randomized controlled studies assessing the effects of IPL on dry eye symptoms or any adverse effects in patients with MGD. Two authors independently screened studies and evaluated the risk of bias. Meta-analysis (random effects model) and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were used to synthesize results and assess certainty of evidence.
Results
In total, 13 studies were included in the review. The risk of bias was assessed as moderate in most results primarily due to the risk of selective reporting. The synthesis and GRADE assessment show that IPL probably results in a clinically relevant reduction in symptoms of dry eyes when compared to placebo (MD = -16 OSDI points; 95% CI = -20 to -12). However, whether the effect is clinically relevant when used as an add-on to standard care is still unclear (MD = -7 OSDI points; 95% CI = -12 to -3). Furthermore, the evidence on adverse events is very uncertain.
Conclusion
Although IPL probably results in a clinically relevant reduction in symptoms of dry eyes when compared to placebo, in practice IPL would typically be used as an add-on to standard treatment. It is therefore essential with further studies investigating whether this use would give a clinically relevant reduction in symptoms, and what the potential harm of IPL is when treating MGD.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Systematic review, Meta-analysis, Risk of bias, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.